Alphaeon Corporation, a subsidiary of Strathspey Crown Holdings LLC, and Clarion Medical Technologies Inc. entered into a definitive agreement for Alphaeon to acquire all of the outstanding shares and assets of Clarion, a provider of medical and aesthetic equipment and consumables in Canada, for an undisclosed sum. The acquisition is expected to close on or before September 30, 2014.

“Over the past twenty-five years, Clarion has shown consistent and profitable growth,” said Robert E. Grant, CEO of Alphaeon. “This acquisition expands Alphaeon's geographic reach and provides early market experience with leading products from around the world, including Teoxane's full-line of dermal fillers, a strong energy device platform, and multiple ophthalmic technologies that provide patients optimal outcomes. We also intend to launch ShoutMD as well as our portfolio of Performance, Wellness and Beauty products in Canada through our unique digital selling approach.

We look forward to partnering closely with the specialty physicians in Canada to advance patient outcomes and experiences.”

“Clarion prides itself on being a trusted strategic partner to Canada's leading physicians, which is why it is important for us to select a partner whose values and customer centricity align s with ours,” said Dan Webb, CEO and Founder of Clarion. “We truly believe that together we will be able to continue to offer innovative solutions and best-in-class service to our physicians and their patients. Most importantly, this transaction provides Clarion access to the ShoutMD proprietary procial (professional and social) media platform, which enables real-time peer-to-peer engagement with the leading physicians within Lifestyle Healthcare, around the world.”